A role for oxytocin and 5-HT1A receptors in the prosocial effects of 3,4 methylenedioxymethamphetamine ("ecstasy")

Neuroscience

Volumn 146, Issue 2, 2007, Pages 509-514

  Thompson, M R ^a   Callaghan, P D ^a   Hunt, G E ^a   Cornish, J L ^b   McGregor, I S ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b MACQUARIE UNIVERSITY   (Australia)

Author keywords

5 HT; 5 HT1A; 8 OH DPAT; MDMA; oxytocin; social behavior

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; OXYTOCIN RECEPTOR; SEROTONIN 1A RECEPTOR; TOCINOIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SOCIAL BEHAVIOR; SOCIAL INTERACTION; THALAMUS MIDLINE NUCLEUS;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; BEHAVIOR, ANIMAL; DRUG INTERACTIONS; ENZYME INHIBITORS; HALLUCINOGENS; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; OXYTOCIN; PIPERAZINES; PROTO-ONCOGENE PROTEINS C-FOS; PYRIDINES; RATS; RATS, WISTAR; RECEPTOR, SEROTONIN, 5-HT1A; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; SOCIAL BEHAVIOR;

EID: 34247267835     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2007.02.032     Document Type: Article

References (20)

1. Cornish J.L., Shahnawaz Z., Thompson M.R., Wong S., Morley K.C., Hunt G.E., and McGregor I.S. Heat increases 3,4-methylenedioxymethamphetamine self-administration and social effects in rats. Eur J Pharmacol 482 (2003) 339-341
2. Emanuele E., Arra M., and Pesenti S. Vasopressin and oxytocin as neurohormonal mediators of MDMA (ecstasy) sociosexual behavioural effects. Med Hypotheses 67 (2006) 1250-1251
3. File S.E., and Seth P. A review of 25 years of the social interaction test. Eur J Pharmacol 463 (2003) 35-53
4. Forsling M.L., Fallon J.K., Shah D., Tilbrook G.S., Cowan D.A., Kicman A.T., and Hutt A.J. The effect of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") and its metabolites on neurohypophysial hormone release from the isolated rat hypothalamus. Br J Pharmacol 135 (2002) 649-656
5. Galfi M., Radacs M., Juhasz A., Laszlo F., Molnar A., and Laszlo F.A. Serotonin-induced enhancement of vasopressin and oxytocin secretion in rat neurohypophyseal tissue culture. Regul Pept 127 (2005) 225-231
6. Greer G., and Tolbert R. Subjective reports of the effects of MDMA in a clinical setting. J Psychoactive Drugs 18 (1986) 319-327
7. Hargreaves G.A., Hunt G.E., Cornish J.L., and McGregor I.S. High ambient temperature increases MDMA ("ecstasy")-induced Fos expression in a region specific manner. Neuroscience 145 (2007) 764-774
8. Jorgensen H., Riis M., Knigge U., Kjaer A., and Warberg J. Serotonin receptors involved in vasopressin and oxytocin secretion. J Neuroendocrinol 15 (2003) 242-249
9. Landgraf R., and Neumann I.D. Vasopressin and oxytocin release within the brain: a dynamic concept of multiple and variable modes of neuropeptide communication. Front Neuroendocrinol 25 (2004) 150-176
10. Lim M.M., and Young L.J. Neuropeptidergic regulation of affiliative behavior and social bonding in animals. Horm Behav 50 (2006) 506-517
11. Morley K.C., Arnold J.C., and McGregor I.S. Serotonin (1A) receptor involvement in acute 3,4-methylenedioxymethamphetamine (MDMA) facilitation of social interaction in the rat. Prog Neuropsychopharmacol Biol Psychiatry 29 (2005) 648-657
12. Morley K.C., and McGregor I.S. (+/-)-3,4-Methylenedioxymethamphetamine (MDMA, "ecstasy") increases social interaction in rats. Eur J Pharmacol 408 (2000) 41-49
13. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates (1998), Academic Press, New York
14. Picazo O., Lopez-Rubalcava C., and Fernandez-Guasti A. Anxiolytic effect of the 5-HT1A compounds 8-hydroxy-2-(di-n-propylamino) tetralin and ipsapirone in the social interaction paradigm: evidence of a presynaptic action. Brain Res Bull 37 (1995) 169-175
15. Solowij N., Hall W., and Lee N. Recreational MDMA use in Sydney: a profile of "ecstacy" [sic] users and their experiences with the drug. Br J Addict 87 (1992) 1161-1172
16. Stephenson C.P., Hunt G.E., Topple A.N., and McGregor I.S. The distribution of 3,4-methylenedioxymethamphetamine "ecstasy"-induced c-fos expression in rat brain. Neuroscience 92 (1999) 1011-1023
17. Verty A.N., McFarlane J.R., McGregor I.S., and Mallet P.E. Evidence for an interaction between CB1 cannabinoid and oxytocin receptors in food and water intake. Neuropharmacology 47 (2004) 593-603
18. Vicentic A., Li Q., Battaglia G., and Van de Kar L.D. WAY-100635 inhibits 8-OH-DPAT-stimulated oxytocin, ACTH and corticosterone, but not prolactin secretion. Eur J Pharmacol 346 (1998) 261-266
19. Vollenweider F.X., Gamma A., Liechti M., and Huber T. Psychological and cardiovascular effects and short-term sequelae of MDMA ("ecstasy") in MDMA-naive healthy volunteers. Neuropsychopharmacology 19 (1998) 241-251
20. Wolff K., Tsapakis E.M., Winstock A.R., Hartley D., Holt D., Forsling M.L., and Aitchison K.J. Vasopressin and oxytocin secretion in response to the consumption of ecstasy in a clubbing population. J Psychopharmacol 20 (2006) 400-410